✦ LIBER ✦

A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study

✍ Scribed by Ursula Wiedermann; C. Wiltschke; J. Jasinska; M. Kundi; R. Zurbriggen; E. Garner-Spitzer; R. Bartsch; G. Steger; H. Pehamberger; O. Scheiner; C. C. Zielinski

Publisher: Springer US
Year: 2009
Tongue: English
Weight: 321 KB
Volume: 119
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-009-0666-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of a HER2/neu bispecific

A phase I study of a HER2/neu bispecific antibody with granulocyte-colony-stimulating factor in patients with metastatic breast cancer that overexpresses HER2/neu

✍ V. Pullarkat; Y. Deo; J. Link; L. Spears; V. Marty; R. Curnow; S. Groshen; C. Ge 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 365 KB

Results of the first phase 1 clinical tr

Results of the first phase 1 clinical trial of the HER-2/neu peptide (GP2) vaccine in disease-free breast cancer patients : United States Military Cancer Institute Clinical Trials Group Study I-04

✍ Mark G. Carmichael; Linda C. Benavides; Jarrod P. Holmes; Jeremy D. Gates; Eliza 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 1 views